Skip to Content

Putnam Global Health Care A PHSTX

Medalist Rating as of | See Franklin Templeton Investment Hub
  • NAV / 1-Day Return 60.74  /  +1.33 %
  • Total Assets 1.7 Bil
  • Adj. Expense Ratio
    1.070%
  • Expense Ratio 1.070%
  • Distribution Fee Level Low
  • Share Class Type Front Load
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment
  • Status Open
  • TTM Yield 0.15%
  • Turnover 41%

USD | NAV as of Apr 23, 2024 | 1-Day Return as of Apr 23, 2024, 10:17 PM GMT+0

Morningstar’s Analysis PHSTX

Will PHSTX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin Putnam Global Health Care A's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PHSTX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 58.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

UnitedHealth Group Inc

8.30 147.2 Mil
Healthcare

Eli Lilly and Co

7.68 136.3 Mil
Healthcare

AbbVie Inc

7.59 134.6 Mil
Healthcare

Intuitive Surgical Inc

6.08 107.9 Mil
Healthcare

AstraZeneca PLC

5.62 99.6 Mil
Healthcare

Novo Nordisk A/S Class B

5.09 90.4 Mil
Healthcare

Boston Scientific Corp

5.05 89.6 Mil
Healthcare

Thermo Fisher Scientific Inc

4.55 80.7 Mil
Healthcare

Innoviva Inc

4.41 78.3 Mil
Healthcare

Ascendis Pharma A/S ADR

4.34 77.0 Mil
Healthcare